Active Ingredient(s): Tobramycin
FDA Approved: * December 22, 1997
Pharm Company: * CHIRON
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

TOBI Overview

Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius and used to treat various types of bacterial infections, particularly Gram-negative infections. It is especially effective against species of Pseudomonas.[1] Contents 1 Medical uses 1.1 Spectrum of susceptibility 2 Side effects 3 Mechanism of action 4 References 5 External links Medical uses Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can o...

Read more TOBI Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent TOBI Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1.2g, 1.2gm/vial, 1.6mg/ml, 10mg/1ml, 10mg/ml, 40mg, 40mg/ml, 60mg, 60mg/50ml, 80mg, 80mg/100ml
  • Ointment: 0.3%, 0.30%
  • Powder: 100%, 28mg
  • Powder for Reconstitution: 1.2g
  • Solution: 0.3%, 300mg/4ml, 300mg/5ml, 60mg/ml
  • Solution/drops: 0.3%, 0.30%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for TOBI: (1 result)

Sorted by National Drug Code
  • 0078-0494 Tobi 300 mg/5ml Oral Solution by Novartis Pharmaceuticals Corporation

Other drugs which contain Tobramycin or a similar ingredient: (12 results)